Ectopic expression of RNF168 and 53BP1 increases mutagenic but not physiological non-homologous end joining

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Ectopic expression of RNF168 and 53BP1 increases mutagenic but not physiological non-homologous end joining. / Zong, Dali; Callén, Elsa; Pegoraro, Gianluca; Lukas, Claudia; Lukas, Jiri; Nussenzweig, André.

In: Nucleic Acids Research, Vol. 43, No. 10, 26.05.2015, p. 4950-61.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Zong, D, Callén, E, Pegoraro, G, Lukas, C, Lukas, J & Nussenzweig, A 2015, 'Ectopic expression of RNF168 and 53BP1 increases mutagenic but not physiological non-homologous end joining', Nucleic Acids Research, vol. 43, no. 10, pp. 4950-61. https://doi.org/10.1093/nar/gkv336

APA

Zong, D., Callén, E., Pegoraro, G., Lukas, C., Lukas, J., & Nussenzweig, A. (2015). Ectopic expression of RNF168 and 53BP1 increases mutagenic but not physiological non-homologous end joining. Nucleic Acids Research, 43(10), 4950-61. https://doi.org/10.1093/nar/gkv336

Vancouver

Zong D, Callén E, Pegoraro G, Lukas C, Lukas J, Nussenzweig A. Ectopic expression of RNF168 and 53BP1 increases mutagenic but not physiological non-homologous end joining. Nucleic Acids Research. 2015 May 26;43(10):4950-61. https://doi.org/10.1093/nar/gkv336

Author

Zong, Dali ; Callén, Elsa ; Pegoraro, Gianluca ; Lukas, Claudia ; Lukas, Jiri ; Nussenzweig, André. / Ectopic expression of RNF168 and 53BP1 increases mutagenic but not physiological non-homologous end joining. In: Nucleic Acids Research. 2015 ; Vol. 43, No. 10. pp. 4950-61.

Bibtex

@article{079426e4e8f34b35a0fb12c7e0df7794,
title = "Ectopic expression of RNF168 and 53BP1 increases mutagenic but not physiological non-homologous end joining",
abstract = "DNA double strand breaks (DSBs) formed during S phase are preferentially repaired by homologous recombination (HR), whereas G1 DSBs, such as those occurring during immunoglobulin class switch recombination (CSR), are repaired by non-homologous end joining (NHEJ). The DNA damage response proteins 53BP1 and BRCA1 regulate the balance between NHEJ and HR. 53BP1 promotes CSR in part by mediating synapsis of distal DNA ends, and in addition, inhibits 5' end resection. BRCA1 antagonizes 53BP1 dependent DNA end-blocking activity during S phase, which would otherwise promote mutagenic NHEJ and genome instability. Recently, it was shown that supra-physiological levels of the E3 ubiquitin ligase RNF168 results in the hyper-accumulation of 53BP1/BRCA1 which accelerates DSB repair. Here, we ask whether increased expression of RNF168 or 53BP1 impacts physiological versus mutagenic NHEJ. We find that the anti-resection activities of 53BP1 are rate-limiting for mutagenic NHEJ but not for physiological CSR. As heterogeneity in the expression of RNF168 and 53BP1 is found in human tumors, our results suggest that deregulation of the RNF168/53BP1 pathway could alter the chemosensitivity of BRCA1 deficient tumors.",
author = "Dali Zong and Elsa Call{\'e}n and Gianluca Pegoraro and Claudia Lukas and Jiri Lukas and Andr{\'e} Nussenzweig",
note = "Published by Oxford University Press on behalf of Nucleic Acids Research 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.",
year = "2015",
month = may,
day = "26",
doi = "10.1093/nar/gkv336",
language = "English",
volume = "43",
pages = "4950--61",
journal = "Nucleic Acids Research",
issn = "0305-1048",
publisher = "Oxford University Press",
number = "10",

}

RIS

TY - JOUR

T1 - Ectopic expression of RNF168 and 53BP1 increases mutagenic but not physiological non-homologous end joining

AU - Zong, Dali

AU - Callén, Elsa

AU - Pegoraro, Gianluca

AU - Lukas, Claudia

AU - Lukas, Jiri

AU - Nussenzweig, André

N1 - Published by Oxford University Press on behalf of Nucleic Acids Research 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.

PY - 2015/5/26

Y1 - 2015/5/26

N2 - DNA double strand breaks (DSBs) formed during S phase are preferentially repaired by homologous recombination (HR), whereas G1 DSBs, such as those occurring during immunoglobulin class switch recombination (CSR), are repaired by non-homologous end joining (NHEJ). The DNA damage response proteins 53BP1 and BRCA1 regulate the balance between NHEJ and HR. 53BP1 promotes CSR in part by mediating synapsis of distal DNA ends, and in addition, inhibits 5' end resection. BRCA1 antagonizes 53BP1 dependent DNA end-blocking activity during S phase, which would otherwise promote mutagenic NHEJ and genome instability. Recently, it was shown that supra-physiological levels of the E3 ubiquitin ligase RNF168 results in the hyper-accumulation of 53BP1/BRCA1 which accelerates DSB repair. Here, we ask whether increased expression of RNF168 or 53BP1 impacts physiological versus mutagenic NHEJ. We find that the anti-resection activities of 53BP1 are rate-limiting for mutagenic NHEJ but not for physiological CSR. As heterogeneity in the expression of RNF168 and 53BP1 is found in human tumors, our results suggest that deregulation of the RNF168/53BP1 pathway could alter the chemosensitivity of BRCA1 deficient tumors.

AB - DNA double strand breaks (DSBs) formed during S phase are preferentially repaired by homologous recombination (HR), whereas G1 DSBs, such as those occurring during immunoglobulin class switch recombination (CSR), are repaired by non-homologous end joining (NHEJ). The DNA damage response proteins 53BP1 and BRCA1 regulate the balance between NHEJ and HR. 53BP1 promotes CSR in part by mediating synapsis of distal DNA ends, and in addition, inhibits 5' end resection. BRCA1 antagonizes 53BP1 dependent DNA end-blocking activity during S phase, which would otherwise promote mutagenic NHEJ and genome instability. Recently, it was shown that supra-physiological levels of the E3 ubiquitin ligase RNF168 results in the hyper-accumulation of 53BP1/BRCA1 which accelerates DSB repair. Here, we ask whether increased expression of RNF168 or 53BP1 impacts physiological versus mutagenic NHEJ. We find that the anti-resection activities of 53BP1 are rate-limiting for mutagenic NHEJ but not for physiological CSR. As heterogeneity in the expression of RNF168 and 53BP1 is found in human tumors, our results suggest that deregulation of the RNF168/53BP1 pathway could alter the chemosensitivity of BRCA1 deficient tumors.

U2 - 10.1093/nar/gkv336

DO - 10.1093/nar/gkv336

M3 - Journal article

C2 - 25916843

VL - 43

SP - 4950

EP - 4961

JO - Nucleic Acids Research

JF - Nucleic Acids Research

SN - 0305-1048

IS - 10

ER -

ID: 139976565